Essais liés2clinical trials
VilleParislocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05999604

Ouvrir le site du centre

Essais cliniques associés

2
MoléculeIndication / populationPhaseNCTTitreStatut
Ocrelizumab Injection [Ocrevus] SEP Phase 3 NCT05999604 WINDOCRE — Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial ACTIVE_NOT_RECRUITING
DIXI Medical Microdeep® Micro- Macro Depth electrodes Épilepsie NA NCT06105645 NENUFAR — Contribution of Fast-ripples to the Improvement of the Neurosurgical Management of Drug-refractory Epilepsy RECRUITING